TEVA PHARMACEUTICAL FIN LLC
(88163VAE9)
ファンドの報告 TEVA PHARMACEUTICAL FIN LLC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Income Research & Management | 15,589,000 | $14,254k | Jun 30, 2019 | Aug 12, 2019 | |
| Whitebox Advisors LLC | 14,000,000 | $12,801k | Jun 30, 2019 | Aug 14, 2019 | |
| Southpaw Asset Management LP | 12,807,000 | $11,758k | Jun 30, 2019 | Aug 14, 2019 | |
| Western Asset Management Company Limited | 10,000,000 | $9,169k | Jun 30, 2019 | Aug 14, 2019 | |
| Western Asset Management Company LLC | 10,000,000 | $9,169k | Jun 30, 2019 | Aug 14, 2019 | |
| Western Asset Management Company Ltd | 10,000,000 | $9,169k | Jun 30, 2019 | Aug 14, 2019 | |
| Graham Capital Management LP | 9,025,000 | $8,277k | Jun 30, 2019 | Aug 14, 2019 | |
| Oaktree Capital Management LP | 7,511,000 | $6,907k | Jun 30, 2019 | Aug 14, 2019 | |
| Aristeia Capital LLC | 4,000,000 | $3,678k | Jun 30, 2019 | Aug 14, 2019 | |
| Edgemoor Investment Advisors Inc | 58,000 | $53k | Jun 30, 2019 | Aug 9, 2019 |